600671.SH
Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 19.84
−3.27%Aug 27, 2026, 09:40 UTC
Tianmu Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 6.3022 million yuan, down 38.50% year-on-year.
Source: